Partnering & Licensing

partnering2

Partnering With Us

TRIANNI is actively seeking to partner with other companies interested in licensing the proprietary Trianni Mouse platform for the development of their own therapeutic monoclonal antibodies. Contact us for more information.

Discovery Partners

TRIANNI’s Discovery Partners include several medium-large pharma partners. Below is representative of those that are publicly announced.

Takeda-01
achaogen-01
merck-logo-01
innovent-01
sanofi-01
austrianni-01
FredHutch
gigagen-01
Immunomic-01
OPT-01

In addition to the above, Trianni, Inc holds agreements with Janssen Biotech, Inc. and  Magenta Therapeutics

Academic Agreements

Trianni, Inc holds licensing agreements with Stanford University and University of Alabama, Birmingham.

Preferred Contract Research Provider Partners